JP2023545084A5 - - Google Patents
Info
- Publication number
- JP2023545084A5 JP2023545084A5 JP2023521639A JP2023521639A JP2023545084A5 JP 2023545084 A5 JP2023545084 A5 JP 2023545084A5 JP 2023521639 A JP2023521639 A JP 2023521639A JP 2023521639 A JP2023521639 A JP 2023521639A JP 2023545084 A5 JP2023545084 A5 JP 2023545084A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- antibody
- allergy
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089809P | 2020-10-09 | 2020-10-09 | |
| US63/089,809 | 2020-10-09 | ||
| US202063116365P | 2020-11-20 | 2020-11-20 | |
| US63/116,365 | 2020-11-20 | ||
| US202163233592P | 2021-08-16 | 2021-08-16 | |
| US63/233,592 | 2021-08-16 | ||
| PCT/JP2021/037481 WO2022075476A1 (en) | 2020-10-09 | 2021-10-08 | Method for treating ox40 related disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545084A JP2023545084A (ja) | 2023-10-26 |
| JP2023545084A5 true JP2023545084A5 (https=) | 2024-10-15 |
Family
ID=81126528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521639A Pending JP2023545084A (ja) | 2020-10-09 | 2021-10-08 | Ｏｘ４０関連疾患を治療するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230383001A1 (https=) |
| EP (1) | EP4225371A4 (https=) |
| JP (1) | JP2023545084A (https=) |
| KR (1) | KR20230084166A (https=) |
| CN (1) | CN116437955A (https=) |
| AU (1) | AU2021358274A1 (https=) |
| CA (1) | CA3198414A1 (https=) |
| IL (1) | IL301935A (https=) |
| MX (1) | MX2023004113A (https=) |
| TW (1) | TW202222343A (https=) |
| WO (1) | WO2022075476A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL326123A (en) * | 2023-07-25 | 2026-03-01 | Inmagene Pte Ltd | Treatment methods for alopecia areata and atopic dermatitis |
| WO2025244002A1 (ja) * | 2024-05-21 | 2025-11-27 | 国立大学法人京都大学 | ベンダムスチンによるｔ細胞の減少を抑制するために使用されるｔ細胞減少抑制剤 |
| WO2025259719A1 (en) * | 2024-06-10 | 2025-12-18 | Walden Biosciences, Inc. | Method of administering an anti-soluble urokinase plasominogen activator receptor antibody for the treatment of kidney disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI461436B (zh) * | 2005-11-25 | 2014-11-21 | Kyowa Hakko Kirin Co Ltd | 人類ｃｄ１３４（ｏｘ４０）之人類單株抗體及其製造及使用方法 |
| WO2017134292A1 (en) * | 2016-02-04 | 2017-08-10 | Glenmark Pharmaceuticals S.A. | Anti-ox40 antagonistic antibodies for the treatment of atopic dermatitis |
| EP3448427A1 (en) * | 2016-04-29 | 2019-03-06 | CureVac AG | Rna encoding an antibody |
| PT3528838T (pt) * | 2016-09-23 | 2023-09-04 | Hoffmann La Roche | Utilizações de antagonistas de il-13 para tratamento de dermatite atópica |
| WO2019229155A1 (en) * | 2018-05-31 | 2019-12-05 | Glenmark Pharmceuticals S.A. | Anti-ox40 antagonistic antibodies and dosage for the treatment of ox40-mediated disorders |
-
2021
- 2021-10-08 IL IL301935A patent/IL301935A/en unknown
- 2021-10-08 JP JP2023521639A patent/JP2023545084A/ja active Pending
- 2021-10-08 KR KR1020237011786A patent/KR20230084166A/ko active Pending
- 2021-10-08 AU AU2021358274A patent/AU2021358274A1/en active Pending
- 2021-10-08 CA CA3198414A patent/CA3198414A1/en active Pending
- 2021-10-08 US US18/248,238 patent/US20230383001A1/en active Pending
- 2021-10-08 WO PCT/JP2021/037481 patent/WO2022075476A1/en not_active Ceased
- 2021-10-08 EP EP21877775.3A patent/EP4225371A4/en active Pending
- 2021-10-08 MX MX2023004113A patent/MX2023004113A/es unknown
- 2021-10-08 TW TW110137584A patent/TW202222343A/zh unknown
- 2021-10-08 CN CN202180068736.0A patent/CN116437955A/zh active Pending